Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2023 Earnings Call Transcript
Operator: Good morning. My name is Kelly. And I'll be your conference operator today.
Stay updated with breaking news from David Lebowitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning. My name is Kelly. And I'll be your conference operator today.
Operator: Good day, and thank you for standing by and welcome to the PTC First Quarter 2023 Financial Results Call. All participants are in a listen-only mode.
Operator: Thank you for standing by. Welcome to Schrödinger's Conference Call to review Fourth Quarter and Full Year 2022 Financial Results.
Operator: Thank you for standing by and welcome to the Alnylam Pharmaceuticals Fourth Quarter 2022 Financial Results Conference Call. As a reminder today's conference call is being recorded.
Operator: Good day, and welcome to the PTC Therapeutics Fourth Quarter 2022 Corporate Update and Financial Results Call. At this time, all participants are in a listen-only mode.